Abstract:Shuxuening injection (SXNI), one of the pharmaceutical preparations of Ginkgo biloba extract, has significant effects on both ischemic stroke and heart diseases from bench to bedside. Its major active ingredients are ginkgo flavonol glycosides (GFGs) and ginkgolides (GGs). We have previously reported that SXNI as a whole protected ischemic brain and heart, but the active ingredients and their contribution to the therapeutic effects remain unclear. Therefore, we combined experimental and network analysis approach to further explore the specific effects and underlying mechanisms of GFGs and GGs of SXNI on ischemia–reperfusion injury in mouse brain and heart. In the myocardial ischemia–reperfusion injury (MIRI) model, pretreatment with GFGs at 2.5 ml/kg was superior to the same dose of GGs in improving cardiac function and coronary blood flow and reducing the levels of lactate dehydrogenase and aspartate aminotransferase in serum, with an effect similar to that achieved by SXNI. In contrast, pretreatment with GGs at 2.5 ml/kg reduced cerebral infarction area and cerebral edema similarly to that of SXNI but more significantly compared with GFGs in cerebral ischemia–reperfusion injury (CIRI) model. Network pharmacology analysis of GFGs and GGs revealed that tumor necrosis factor-related weak inducer of apoptosis (TWEAK)–fibroblast growth factor-inducible 14 (Fn14) signaling pathway as an important common mechanism but with differential targets in MIRI and CIRI. In addition, immunohistochemistry and enzyme linked immunosorbent assay (ELISA) assays were performed to evaluate the regulatory roles of GFGs and GGs on the common TWEAK–Fn14 signaling pathway to protect the heart and brain. Experimental results confirmed that TWEAK ligand and Fn14 receptor were downregulated by GFGs to mitigate MIRI in the heart while upregulated by GGs to improve CIRI in the brain. In conclusion, our study showed that GFGs and GGs of SXNI tend to differentially protect brain and heart from ischemia–reperfusion injuries at least in part by regulating a common TWEAK–Fn14 signaling pathway.

Biginkgosides A-I, Unexpected Minor Dimeric Flavonol Diglycosidic Truxinate and Truxillate Esters from Ginkgo Biloba Leaves and Their Antineuroinflammatory and Neuroprotective Activities

Isolation and Identification of Constituents with Activity of Inhibiting Nitric Oxide Production in RAW 264.7 Macrophages from Gentiana Triflora.

Two New Phenylethanoid Glycosides from Ginkgo Biloba Leaves and Their Tyrosinase Inhibitory Activities.

Structurally Diverse Sesquiterpenoid Glycoside Esters from Pittosporum qinlingense with Anti-neuroinflammatory Activity

NO Inhibitory Constituents from Glycosmis Craibii Var. Glabra

Total Synthesis of Ginkgolide C and Formal Syntheses of Ginkgolides A and B

Flavonol glycosides and phenylpropanoid glycosides with inhibitory effects on microglial nitric oxide production from Neoshirakia japonica

Study on Synergistic Anti-Inflammatory Effect of Typical Functional Components of Extracts of Ginkgo Biloba Leaves

Identification and quantification of the antioxidants in Ginkgo biloba leaf

Flavaglines with anti-neuroinflammatory activity from Aglaia edulis (Roxb.) Wall. and structure revision of related flavaglines

Study on Synergistic Antioxidant Effect of Typical Functional Components of Hydroethanolic Leaf Extract from Ginkgo Biloba In Vitro

Two new quinoline alkaloid with neuroprotective activities from Xylaria longipes

Two new neolignans and an indole alkaloid from the stems of Nauclea officinalis and their biological activities

Ginkgo Flavonol Glycosides or Ginkgolides Tend to Differentially Protect Myocardial or Cerebral Ischemia–Reperfusion Injury via Regulation of TWEAK-Fn14 Signaling in Heart and Brain

New Coumarins from the Roots of Angelica Dahurica Var. Formosana Cv. Chuanbaizhi and Their Inhibition on NO Production in LPS-activated RAW264.7 Cells.

(+)- and (-)-corydecumbenines A and B, Two Pairs of Novel Quaternary Protoberberine Alkaloid Cycloadduct Enantiomers with Anti-Neuroinflammatory and Neuroprotective Activities from the Rhizomes of Corydalis Decumbens

Anti-neuroinflammatory constituents from Polygala tricornis Gagnep.

New phenylbutenoids and terpene glycosides from Ginkgo biloba leaves

Ginkgo biloba and Its Constituent 6-hydroxykynurenic-acid as well as Its Proanthocyanidins Exert Neurorestorative Effects against Cerebral Ischemia

Ginkgetin exerts anti-inflammatory effects on cerebral ischemia/reperfusion-induced injury in a rat model via the TLR4/NF-κB signaling pathway

A new C-glycosyl flavone and a new neolignan glycoside from Passiflora edulis Sims peel